학술논문

FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation–Positive Low-Grade Glioma
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 January 2024, 30(2):263-268)
Subject
Language
English
ISSN
15573265
10780432